• Corpus ID: 9049598

The financial burden of cancer: estimates from a study of insured women with breast cancer.

  title={The financial burden of cancer: estimates from a study of insured women with breast cancer.},
  author={Ahsan M. Arozullah and Elizabeth A. Calhoun and Michael S. Wolf and Denise Finley and Karen A. Fitzner and Elizabeth A Heckinger and Nicolle Gorby and Glen T. Schumock and Charles L. Bennett},
  journal={The journal of supportive oncology},
  volume={2 3},
The financial impact of cancer can be large, even among persons with comprehensive health insurance policies. Prior studies have found that women with cancer are especially likely to suffer financial hardship. Although controversial, cancer insurance policies are designed to reduce the financial burden of cancer. In this study, we provide estimates of the costs incurred by a cohort of breast cancer patients who were covered by private, Medicare, or Medicaid health insurance. In all, 156 women… 

Cost considerations in the management of cancer in the older patient.

Major sources of direct medical expenditures covered by third-party insurers for patients aged 65 years and older include extended length of hospital stay, home health assistance following hospital discharge, adjuvant prescription medications, lower-risk treatment (for prostate cancer), and advent of new pharmaceuticals (for colorectal cancer).

The financial toxicity of cancer treatment: a pilot study assessing out-of-pocket expenses and the insured cancer patient's experience.

Insured patients undergoing cancer treatment and seeking copayment assistance experience considerable subjective financial burden, and they may alter their care to defray out-of-pocket expenses.

Impact of Increasing Out-of-Pocket Costs for Insured Cancer Patients

  • Medicine, Political Science
  • 2017
The OPCs for cancer patients covered by health plans are increasing and becoming a financial burden that may be exacerbated by a concomitant loss of income, so health plans need to evaluate whether pursuing cost-shifting strategies is in the best interests of both patients and health plans over the long term.

Financial Burden of Managing Metastatic Breast Cancer in Sub- Saharan African.

The extent and effect of the financial hardship in managing metastatic breast cancers in a low income country located in Sub-Saharan African is determined and the need for screening programmes that will encourage early diagnosis and introduction of health insurance scheme to wider population is suggested.

The financial impact of a cancer diagnosis

The costs to the health services of the diagnosis and treatment of cancer are substantial. These costs have increased over the past decades and are expected to rise further in coming years with

The financial burden of cancer: Estimates from patients undergoing cancer care in a tertiary care hospital

The study indicates that the financial burden of cancer care is substantial and can be overwhelming and there is a desperate need for treatment support programs either by the government or other welfare organisations to support individuals and families who are already facing a difficult and challenging situation.

National estimates of out-of-pocket health care expenditure burdens among nonelderly adults with cancer: 2001 to 2008.

Although a detailed patient-physician discussion of costs of care may not be feasible, it is believed that an awareness of out-of-pocket burdens among patients with cancer is useful for clinical oncologists.

Long-term financial burden of breast cancer: experiences of a diverse cohort of survivors identified through population-based registries.

Racial and ethnic minority patients appear most vulnerable to privations and financial decline attributable to breast cancer, even after adjustment for income, education, and employment.

Wage losses in the year after breast cancer: extent and determinants among Canadian women.

Wage losses and their effects on financial situation constitute an important adverse consequence of breast cancer in Canada.

The Costs of Treating Breast Cancer in the US

Most lifetime cost estimates were likely an underestimate for today’s lifetime cost of treating breast cancer because of changes in practice patterns and improved survival, and further societal-based cost studies that differentiate costs by stage, age and treatment time (initial, continuing and terminal), and include the latest practice patterns are valuable.



Breast cancer patients' out-of-pocket expenses.

Out-of-pocket expenses for transportation, food supplements, over-the-counter medications, distractions, telephone bills, insurance premiums, and alternative treatment incurred since diagnosis ranged from $20 to $3700, and excluded expenses for health providers.

Family and out-of-pocket costs for women with breast cancer.

Informal costs of women who survived for at least 3 months after the observation are compared with informal costs of a group of patients who died during the subsequent 3 months.

Estimating the cost of informal caregiving for elderly patients with cancer.

  • J. HaymanK. Langa A. Fendrick
  • Medicine, Political Science
    Journal of clinical oncology : official journal of the American Society of Clinical Oncology
  • 2001
Informal caregiving costs are substantial and should be considered when estimating the cost of cancer treatment in the elderly, and were estimated to be $1,200 per patient and just over $1 billion nationally.

Evaluating the total costs of chemotherapy-induced toxicity: results from a pilot study with ovarian cancer patients.

Estimation of the total costs of cancer-related toxicities is feasible with the assistance of patients who are experiencing toxicity, according to detailed and comprehensive cost information obtained from patients who experienced neutropenia, thrombocytopenia or neurotoxicity during treatment.

Nonmedical costs to patients and their families associated with outpatient chemotherapy

One hundred thirty‐nine patients receiving outpatient chemotherapy kept diaries of nonmedical expenses resulting from their disease and its treatment, and a method is proposed for using these data to estimate total non medical expenses for different treatment regimens, and also for estimating cancer patients' total nonmedical costs nationally.

The burden of illness of cancer: economic cost and quality of life.

This chapter analyzes the main measures of burden of disease as relate to cancer, including incidence and mortality, years of life lost from cancer, and cancer prevalence, and examines the impact of cancer on health- related quality of life as measured in global terms and using evaluation-oriented applications of health-related quality ofLife scales.

The Impact of Serious Illness on Patients' Families

Many families of seriously ill patients experience severe caregiving and financial burdens, and families of younger, poorer, and more functionally dependent patients are most likely to report loss of most or all of the family's savings.

Evaluating the total costs of cancer. The Northwestern University Costs of Cancer Program.

The theoretical framework associated with a study of cancer costs is outlined and findings from ongoing pilot studies in this area are summarized.

The cost of cancer home care to families

A major component of indirect costs, the family labor expended to care for the patient with cancer, needs to be included for a more realistic appreciation of home care costs.

The association between physician reimbursement in the US and use of hematopoietic colony stimulating factors as adjunct therapy for older patients with acute myeloid leukemia: Results from the 1997 American Society of Clinical Oncology survey

Physicians in the US are mixed in their support for CSFs for older AML patients, with support high in settings where CSF use was accompanied by financial profit to the physician practice, and support was low otherwise.